Healthcare -
Biotechnology - NASDAQ - US
$ 6.195
-13.2 %
$ 974 M
Market Cap
-4.8
P/E
OCUL - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative OCUL - Ocular Therapeutix, Inc.
74.5 M
LAST VALUE
5.39%
2 YEAR CAGR
25.71%
5 YEAR CAGR
41.07%
10 YEAR CAGR